Email Sign-Up Go to Shopping Cart (0)
 
 
EVERYDAY LOW PRICES ON PET SUPPLIES - 100% SATISFACTION GUARANTEE - FREE SHIPPING on orders $49 or more*
HOME »    ARTICLES »    PHARMACY »    MEDICATION SPOTLIGHTS »    PHARMACY SPOTLIGHT: ATOPICA®
Refills
Save Time! Download our Prescription Fax Form PDF before you go to the veterinarian
Pet owners stay informed
Our Heartworm
Guarantee
Flea & Tick
No prescription required for Flea & Tick Control
Horses
Ferrets
Ordering Information
Full Prescription
Product List
Veterinarians
FREE Prescription Resource Guides
Pharmacy Articles
About Our Pharmacy
1-800-447-3021
Disposal of Unused Medicines

  

Pharmacy Spotlight: Atopica®


Drs. Foster & Smith Educational Staff
TOP VIEWED ARTICLES
Introducing Quellin™ (Carprofen) Soft Chews from Bayer 
Pharmacy Spotlight: Ketoconazole (Nizoral) 
Pharmacy Spotlight: Corticosteroids 
PRODUCTS RELATED TO:
Medication Spotlights
Ketoconazole (Generic)
Ketoconazole (Generic)
As low as $1.49
Comfortis Chewable Tablets (Brand)
Comfortis Chewable Tablets (Brand)
As low as $89.99
Spotlight on Atopica

Atopica

  • Medication type: Prescription-only, immune system suppressant


  • Active ingredient: Cyclosporine


  • Dosage form: Capsule


  • Manufacturer: Novartis


  • Major use: Used to treat atopy (an allergy to airborne substances) in dogs. The active ingredient is cyclosporine, which suppresses the immune system.

  • How it works: Cyclosporine suppresses the immune system mainly through actions on lymphocytes, which are certain white blood cells involved in the immune response. Precautions: Contact your veterinarian if your pet experiences loss of appetite, vomiting, diarrhea, overgrowth of the gums, muscle cramps, increased hair growth, increased thirst, increased urination, jaundice (yellowing of gums, skin, or whites of the eyes), or lethargy while being treated with Atopica.

For full details on this medication, download the free patient information sheet.

Click here for a more printer-friendly version of this article.  
Click here for a pdf version of this article.  

 

 



Contact us